An automated, parallel, solid-phase synthesis and screening strategy using commercially available aryl acetic acids as starting materials has discovered novel, non-peptide CCR1 antagonists (K(i) < 100 nM).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2174/1386207024607284 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!